Interestingly, protein expression levels of IGFBP2 in AEC2 cells were significantly lower in the COVID-ARDS group compared with the IPF alone, or IPF with COVID history disease groups. This evidence concerns the gene IGFBP2 and acute respiratory distress syndrome.